Sagimet Biosciences Inc. (SGMT)
NASDAQ: SGMT · Real-Time Price · USD
6.90
-0.47 (-6.38%)
At close: May 15, 2026, 4:00 PM EDT
7.02
+0.12 (1.74%)
After-hours: May 15, 2026, 7:27 PM EDT

Sagimet Biosciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
426193145124--
Market Cap Growth
236.75%32.89%16.75%---
Enterprise Value
321.5979.4-6.3729.200
Last Close Price
6.905.924.505.42--
PE Ratio
--3.75-3.10-2.04--
PS Ratio
---62.05--
PB Ratio
2.191.730.931.36--
P/TBV Ratio
2.181.720.910.62--
P/FCF Ratio
--4.22-3.41-5.22--
P/OCF Ratio
--4.22-3.41-5.22--
EV/Sales Ratio
---14.60--
EV/EBITDA Ratio
--1.400.12-0.95--
EV/EBIT Ratio
--1.400.12-0.95--
EV/FCF Ratio
--1.740.15-1.23--
Debt / Equity Ratio
-0000.000.00
Debt / EBITDA Ratio
0.000.000.000.00-0.01-0.01
Debt / FCF Ratio
0.000.000.000.00-0.01-0.02
Net Debt / Equity Ratio
-1.02-1.01-0.97-1.040.170.36
Net Debt / EBITDA Ratio
2.141.992.783.091.032.38
Net Debt / FCF Ratio
2.632.483.563.991.312.60
Asset Turnover
-000.0300
Quick Ratio
19.7422.1833.9616.786.1323.25
Current Ratio
20.3422.8234.3017.096.2124.04
Return on Equity (ROE)
-40.70%-38.20%-36.92%-46.96%-72.59%-36.98%
Return on Assets (ROA)
-43.47%-41.11%-42.38%-47.38%-67.46%-34.09%
Return on Invested Capital (ROIC)
2629.46%-3833.49%-12576.00%747.29%1387.93%1881.71%
Return on Capital Employed (ROCE)
-45.58%-42.58%-44.12%-51.74%-73.64%-35.74%
Earnings Yield
-10.21%-26.69%-32.22%-49.08%--
FCF Yield
--23.71%-29.29%-19.15%--
Buyback Yield / Dilution
-0.92%-3.17%-199.71%-5565.88%0.00%-91.20%
Total Shareholder Return
-0.92%-3.17%-199.71%-5565.88%0.00%-91.20%
Updated May 12, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q